evaluating efficacy of combination therapy with microdermabration and topical Bimatoprost in comparison with topical Bimatoprost alone in vitiligo

Comparison of efficacy of combined microdermabration and topical Bimatoprost with topical Bimatoprost alone in vitiligo patients refered to Afzalipur Hospital in Kerman

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220129053866N1

Enrollment

Registered

2022-10-02

Start date

2022-03-21

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo. Vitiligo

Interventions

Intervention 1: Intervention group: treatment with topical Bimatoprost (exilia 0.03%,inoclon company)(two times in day) and microderm abrasion (every two weeks). Intervention 2: Control group: treatm

Eligibility

Sex/Gender

All

Age

5 Years to 18 Years

Inclusion criteria

Inclusion criteria: patients with vitiligo with age

Exclusion criteria

Exclusion criteria: segmental vitiligo received treatment in 3 past months pregnancy lactation hypertension history asthma history allergy to drug components

Design outcomes

Primary

Measure	Time frame
Repigmentation type. Timepoint: at base line and 1,2,3 and 6 months later. Method of measurement: physical exam.;Repigmentation percentage. Timepoint: at base line and 1,2,3 and 6 months later. Method of measurement: physical exam.	—

Secondary

Measure	Time frame
Pruritis. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.;Scaling. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.;Erythema. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.	—

Measure

Time frame

Pruritis. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.;Scaling. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.;Erythema. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRezvan Amiri

Kerman University of Medical Sciences

rezvanamiri1358@yahoo.com+98 34 3132 8326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026